EU Publications Archives

Ending stigma and discrimination – everyone deserves dignity and care for liver health

2nd May 2025
Chiara Hartmann

Stigma and discrimination fuel health disparities and worsen outcomes for individuals with liver disease. To address these challenges, we must shift the focus from individual blame to the broader social determinants of health. Learning from successful approaches in HIV, mental health, diabetes, and cancer, we must implement targeted interventions that reduce stigma, expand healthcare access, and promote equity.
Full version of Policy Statement

The European Association for the Study of the Liver (EASL) calls on the EU to accelerate public health policies to reduce the high human and financial burden of liver diseases

27th May 2024
Chiara Hartmann

With this statement, EASL reiterates evidence-based recommendations to the European Union Institutions for the next political term, to address boldly the human and financial burden of liver disease in Europe. We can no longer ignore the enormous impact on millions…

Call to Action for the new EU legislature 2024-2029

12th January 2024
Adonia DHANJAL

In view of the new EU legislature 2024-2029, the ACHIEVE Coalition released a Call to Action as the EU as a whole is not on track for viral hepatitis elimination. The Call states the main obstacles to viral hepatitis B…

73rd Session of the WHO Regional Committee for Europe – Action plan for refugee and migrant health in the WHO European region 2023-2030

21st October 2023
Chiara Hartmann
0 Comments

The European Association for the Study of the Liver welcomes the Action plan regarding equity in refugee and migrant health in the WHO European region 2023-2030. EASL supports this timely initiative and the five guiding principles of the plan. These…

73rd Session of the WHO Regional Committee for Europe – Statement on agenda item 11 – Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD)

21st October 2023
Chiara Hartmann
0 Comments

The European Association for the Study of the Liver welcomes the Fourteenth General Programme of Work 2025-2028 (GPW14) consultation document and would like to draw attention to the importance of recognising the burden of Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD),…

Revision of the European Code Against Cancer under EU4Health (2022-2025)

28th August 2023
Adonia DHANJAL
0 Comments

Considering most liver cancer cases are caused by viral hepatitis, 54% of liver cancer diagnoses are due to HBV infection and 31% to HCV infection1, EASL would like to see the new European Code Against Cancer provide more comprehensive information…

EASL response to the consultation on the Scottish Government initiative to Restricting alcohol advertising and promotion

27th March 2023
Adonia DHANJAL
0 Comments

EASL supports in full the consultation responses provided by Scottish Health Action on Alcohol Problems (SHAAP) and Alcohol Focus Scotland to the Scottish Government initiative to Restricting alcohol advertising and promotion.

EASL response to the European Commission Call for evidence for cancer prevention – action to promote vaccination against cancer-causing

7th February 2023
Adonia DHANJAL
0 Comments

EASL welcomes the initiative of the European Commission to propose actions to increase the uptake of vaccination against the Hepatitis B virus and human papillomaviruses. In its response, EASL calls on the EU Member States to prioritise key actions, especially…

EASL contribution to the European Cancer Inequality Registry

25th November 2022
Adonia DHANJAL
0 Comments

The European Association for the Study of the Liver (EASL) welcomes the European Commission’s initiative to build an EU Cancer Inequalities Registry and recommends the inclusion of inequalities in liver cancer and in its key causes: liver cirrhosis due to…

Joint Statement for the 72nd Session of the WHO Regional Committee for Europe, European Framework for Action on Alcohol 2022-2025

15th September 2022
Adonia DHANJAL
0 Comments

EASL endorsed a Joint Statement, together with other 15 organisations. EASL welcomes the European framework for action on alcohol 2022–2025 and endorses the evidence-based language of the Framework and supports the six areas for priority action.